Rheumatoid Arthritis News

Patients with rheumatoid arthritis who underwent a biologic and/or disease-modifying antirheumatic drug taper were more likely to experience flares and have a shorter time to flare, said a speaker at ACR Convergence 2021.

The COVID-19 pandemic brought with it a significant decrease in autoimmunity laboratory testing, first rheumatology visits and diagnoses from 2019 to 2020, according to Italian data published in The Journal of Rheumatology.

A median of just 16.2% of adults with arthritis attended a self-management class in 2019, while that same year 69.3% received counseling for physical activity from their provider, according to CDC researchers.

Most patients with rheumatoid arthritis were involved in conversations about treatment decisions with their rheumatologist, according results of a multinational European survey presented at ACR Convergence 2021.

Baseline use of rituximab compared with conventional synthetic disease-modifying antirheumatic drugs was associated with worse COVID-19 outcomes in patients with rheumatoid arthritis, according to a presenter at ACR Convergence 2021.

Female sex was identified as a baseline predictor of increased odds of both nausea and alopecia in patients with rheumatoid arthritis beginning methotrexate treatment, according to data presented at ACR Convergence 2021.

A 2019 European Medicines Agency warning that tofacitinib could increase risk for venous thromboembolism in patients with rheumatoid arthritis did not affect characteristics of patients starting the drug since then, according to a study.

In this video, Jeffrey A. Sparks, MD, MMSc, provides a review of the ARIAA study presented at ACR Convergence 2021.

Calprotectin was found to be related to ultrasound synovitis scores in patients with rheumatoid arthritis treated with interleukin-6 inhibitors and janus kinase inhibitors, according to a poster presented at ACR Convergence 2021.

In this video, Jeffrey A. Sparks, MD, MMSc, discusses cluster-analysis data from ACR Convergence 2021, which investigated multimorbidity patterns among patients with rheumatoid arthritis.